Algorithm for management of patients with X-ray endovascular artery embolization of the prostate for its benign hyperplasia

X-ray endovascular prostatic artery embolization (XEPAE) is a comparatively new alternative treatment for benign prostatic hyperplasia (BPH), which has shown good results in Russia and foreign countries. The dissimilarity from other treatments for this nosology is the use of superselective artery ischemia of the prostate, which leads to a decrease in its sizes and a progressive reduction in lower urinary tract symptoms. Twelve patients aged 59–71 years (mean age, 66 years) with BPH have been operated on since 2014. The mean follow-up period was 8.4 months (3–17 months). The patients were divided into 3 groups in accordance with prostate volume: 1) 60–100 cm3 (n = 3); 2) 100–200 сm3 (n = 5); 3) ≥ 200 см3 (n = 4). The mean prostatic specific antigen level was 5.1 ± 2.7 ng/ml (2.7–6.3 ng/ml). Due to the increased pro static specific antigen level up to 4 ng/ml, 6 patients underwent transrectal and/or targeted biopsy of the prostate, which failed to reveal the morphological signs of its malignant process. The examination algorithm included all necessary laboratory and clinical examinations, as those during surgery for BPH, as well as multislice spiral computed tomography and/or magnetic resonance imaging, angiography of small pelvic vessels and organs.  Postoperative patient monitoring revealed that the total International Prognostic Scoring System scores decreased by 41.3 and 61.4 % at 3- and 6-month follow-ups, respectively; then these values were insignificant. The prostate volume substantially decreased at 3 months; but at 6 months it was 47 % of the baseline one. The urine flow rate rose from 6.7 to 15.9 ml/sec. The quality of life index became summarily quite satisfactory at 6-month follow-up and amounted to 3.3 ± 1.3. Thus, it may be stated that XEPAE is a safe and highly effective treatment for BPH if its medical treatment is ineffective. This surgical treatment performed for 3–6 months substantially decreases the prostate, normalizes urination, and restores quality of life. Patients with severe comorbidity and a high operative-anesthetic risk should be a promising area in the use of this technique. Patients with cystostome and preserved bladder capacity and those with acute urinary retention in the presence of BPH will serve as important additional areas in the application of XEPAE

SYNTHESIS OF N,S-CONTAINING COMPOUNDS USING (ISO)THIOCYANIC ACID SURROGATES

This work was supported by the Russian Science Foundation, project # 21-73-10212

Pan-Eurasian Experiment (PEEX): Towards a holistic understanding of the feedbacks and interactions in the land-Atmosphere-ocean-society continuum in the northern Eurasian region

The northern Eurasian regions and Arctic Ocean will very likely undergo substantial changes during the next decades. The Arctic-boreal natural environments play a crucial role in the global climate via albedo change, carbon sources and sinks as well as atmospheric aerosol production from biogenic volatile organic compounds. Furthermore, it is expected that global trade activities, demographic movement, and use of natural resources will be increasing in the Arctic regions. There is a need for a novel research approach, which not only identifies and tackles the relevant multi-disciplinary research questions, but also is able to make a holistic system analysis of the expected feedbacks. In this paper, we introduce the research agenda of the Pan-Eurasian Experiment (PEEX), a multi-scale, multi-disciplinary and international program started in 2012 (https://www.atm.helsinki.fi/peex/). PEEX sets a research approach by which large-scale research topics are investigated from a system perspective and which aims to fill the key gaps in our understanding of the feedbacks and interactions between the land-Atmosphere-Aquatic-society continuum in the northern Eurasian region. We introduce here the state of the art for the key topics in the PEEX research agenda and present the future prospects of the research, which we see relevant in this context

Endovascular treatment of vasculogenic erectile dysfunction

Method of choice for surgical treatment of vasculogenic erectile dysfunction (ED) is the genesis of arteriovenous falloprosthetics. In the initial stages of the disease, young men, dissatisfied inhibitor therapy 5-phosphodiesterase and/or intracavernous injections do not agree to such a view of his proposed lecheniya. Authors give the results we operated 26 patients 25–48 year old (mean age 34.3± 7.4) with vasculogenic ED. Of these, 23 patients with venoocclusive ED, 3 patients had arterial insufficiency of the corpora cavernosa. Of these 3 patients, 2 were haemodynamic and clinical features with arteriovenous ED step subcompensation. Maximum period of observation data up was 23 months. Overall clinical compensation of these patients and subsequent sexual rehabilitation was evaluated as satisfactory: the total value of transactions amounted to international index of erectile function 9–13 (10.5 ± 3.6), after surgery 14–25 (21.3 ± 4.2) (p = 0.001). Use this innovative technology allows you to make a sexual rehabilitation most of these patients and avoid falloprosthetics.</em

A CASE OF MYELOBLASTIC BLOOD REACTION IN PATIENTS WITH GENERALIZED TUBERCULOSIS AND AIDS

The paper describes a case of myeloblastic blood response in a patient with severe generalized tuberculosis in the presence of acquired human immunodeficiency syndrome.</p